Finance

Lists
KNSA:NASDAQ
Kiniksa Pharmaceuticals Internatinl, PLC
77,83 US$
-0,41%
(-0,32) 1D
77,83 US$
0,00% (0,00)
After hours
Closed: 13 აგვ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KNSA...
Open
78,65 US$
High
79,69 US$
Low
77,20 US$
Mkt. cap
6,07 მლრდ.
Avg. vol.
696,30 ათ.
Volume
451,21 ათ.
P/E ratio
79,18
52-wk high
82,94 US$
52-wk low
32,82 US$
EPS
0,98 US$
Beta
0,05
Shares outstanding
48,29 მლნ.
No. of employees
366
Open
78,65 US$
High
79,69 US$
Low
77,20 US$
Mkt. cap
6,07 მლრდ.
Avg. vol.
696,30 ათ.
Volume
451,21 ათ.
P/E ratio
79,18
52-wk high
82,94 US$
52-wk low
32,82 US$
EPS
0,98 US$
Beta
0,05
Shares outstanding
48,29 მლნ.
No. of employees
366
News stories
From web sources and news partners
About Kiniksa Pharmaceuticals Internatinl, PLC
CEO-
Employees366
Founded2015
Headquartersლონდონი, ინგლისი, გაერთიანებული სამეფო
Sector-
Analyst ratings
Based on 7 analysts giving stock ratings to KNSA in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for KNSA in the last 3 months.
Highest
Current 77,83 US$
107,00 US$ (+37,48%)
Average
96,57 US$ (+24,08%)
Lowest
87,00 US$ (+11,78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Edward Nash
Canaccord Genuity
Buy
Reiterated
98,00 US$
+25,9%
08/12/2026
Paul Choi
Goldman Sachs
Buy
Maintained
90,00 US$
+15,6%
07/30/2026
David Nierengarten
Wedbush
Buy
Reiterated
99,00 US$
+27,2%
07/28/2026
Anupam Rama
J.P. Morgan
Buy
Reiterated
107,00 US$
+37,5%
07/29/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Reiterated
87,00 US$
+11,8%
07/29/2026
Geoff Meacham
Citi
Buy
Maintained
100,00 US$
+28,5%
07/29/2026
Nicholas Lorusso
TD Cowen
Buy
Maintained
95,00 US$
+22,1%
07/28/2026
Roger Song
Jefferies
Buy
Maintained
71,00 US$
-8,8%
04/28/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
53,00 US$
-31,9%
04/14/2026
Last report
28 ივლ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
0,30 US$ / 0,28 US$
+5,26%beat
Revenue / Est. (USD)
243,60 მლნ. / 226,46 მლნ.
+7,57%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
180,86 მლნ.
202,13 მლნ.
214,27 მლნ.
243,60 მლნ.
Cost of goods sold
83,56 მლნ.
90,98 მლნ.
96,37 მლნ.
111,64 მლნ.
Cost of revenue
83,56 მლნ.
90,98 მლნ.
96,37 მლნ.
111,64 მლნ.
Research and development expenses
24,17 მლნ.
34,61 მლნ.
27,48 მლნ.
40,90 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
49,10 მლნ.
56,78 მლნ.
61,15 მლნ.
63,87 მლნ.
Operating expense
73,27 მლნ.
91,38 მლნ.
88,63 მლნ.
104,76 მლნ.
Total operating expenses
156,83 მლნ.
182,36 მლნ.
185,00 მლნ.
216,41 მლნ.
Operating income
24,02 მლნ.
19,77 მლნ.
29,27 მლნ.
27,19 მლნ.
Other non operating income
3,14 მლნ.
3,50 მლნ.
3,41 მლნ.
3,95 მლნ.
EBT including unusual items
27,16 მლნ.
23,27 მლნ.
32,68 მლნ.
31,14 მლნ.
EBT excluding unusual items
27,16 მლნ.
23,27 მლნ.
32,68 მლნ.
31,14 მლნ.
Income tax expense
8,72 მლნ.
9,07 მლნ.
10,09 მლნ.
5,71 მლნ.
Effective tax rate
32,12%
38,98%
30,87%
18,34%
Other operating expenses
-
-
-
-
Net income
18,44 მლნ.
14,20 მლნ.
22,59 მლნ.
25,43 მლნ.
Net profit margin
10,19%
7,02%
10,54%
10,44%
Earnings per share
0,23
0,17
0,27
0,30
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
24,40 მლნ.
20,24 მლნ.
29,74 მლნ.
27,67 მლნ.
Gain or loss from assets sale
-43,00 ათ.
-53,00 ათ.
-54,00 ათ.
22,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google აპები